Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Two K-9 units recently introduced by the, Va. Police Department have already assisted in getting illegal drugs off the streets. In a statement released by the police department, the agency said the ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Novo Nordisk's stock (NVO) rose more than 8% in Friday trading on news that the company's latest weight-loss product ...

Derek Maltz, a veteran of the Drug Enforcement Administration, is expected to help lead Trump's effort to fight fentanyl ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

New legislation would help set caps on the upper limit of drug costs in Maryland. Prescription drug prices have soared, ...